GAA and metabolic myopathy: Finally, some specific disorders can be treated with targeted therapy (the use of supplements to replenish the affected deficiency in metabolic myopathies, such as the recombinant human acid alpha-glucosidase (rhGAA) enzymatic replacement therapy in Pompe’s disease) [57].